Many countries have not reached their peak in cases of the highly transmissible Omicron variant of the coronavirus and measures imposed to curb its spread should be eased slowly, the World Health Organization’s technical lead on COVID-19 said on Tuesday (Feb. 1). WHO Director-General Tedros Adhanom Ghebreyesus said the U.N. agency was concerned about a…
Many Countries Yet to See Peak in Omicron Wave, Should Ease Curbs Slowly: WHO
WHO: ‘No Indication’ New Omicron Variant More Severe Than Original
Officials with the World Health Organization (WHO) on Tuesday said there is no indication that the COVID-19 Omicron sub-variant BA.2 is more severe than Omicron’s original strain. “There’s no indication that there’s a change in severity,” Maria Van Kerkhove, the WHO’s technical lead for the CCP (Chinese Communist Party) virus, said during a news briefing on…
New Study on Ivermectin ‘Should Convince Any Naysayer’: Dr. Pierre Kory
A recently published study indicating the anti-parasitic ivermectin worked well as a prophylactic against the virus that causes COVID-19 should help sway critics of the drug, according to Dr. Pierre Kory, president of the Front Line COVID-19 Critical Care Alliance (FLCCC). “That should convince any naysayer,” Kory told The Epoch Times’ “American Thought Leaders.” “What…
Tens of Thousands of Tons of Medical Waste Produced During COVID-19 Pandemic Threatens Health: WHO
February 1, 2022
admin
CCP VirusCOVIDEnvironmentEnvironmentalInternationalmedical wastePUBLIC HEALTH INFORMATIONScienceWorld
0 Comment
The tens of thousands of tons of medical waste produced as a result of the COVID-19 pandemic poses a threat to human and environmental health, the World Health Organization (WHO) warned in a report on Tuesday. The extra waste is “threatening human and environmental health and exposing a dire need to improve waste management practices,” the…
New Drug for Seriously Ill COVID-19 Patients Shows Promise Under Right to Try Act
New information collected under the federal Right to Try Act shows promise for the new drug ZYESAMI, now in clinical trials for the treatment of serious cases of COVID-19. The information was collected by a hospital in the U.S. southwest, drug developer NRx announced in a news release Jan. 26. ZYESAMI, developed by the Radnor,…
Spotify Adding COVID-19 Content Advisories to Podcast Episodes to ‘Combat Misinformation’ After Pulling Neil Young’s Music
Spotify will be adding content advisories to podcast episodes in an effort to combat misinformation about COVID-19, the company’s chief executive officer, Daniel Ek has announced. In a blog post published on Jan. 30, the Swedish audio streaming service said it was “working to add a content advisory to any podcast episode that includes a discussion about…
Spotify Adding COVID-19 Content Advisories to Podcast Episodes to ‘Combat Misinformation’
Spotify will be adding content advisories to podcast episodes in an effort to combat misinformation about COVID-19, the company’s chief executive officer, Daniel Ek has announced. In a blog post published on Jan. 30, the Swedish audio streaming service said it was “working to add a content advisory to any podcast episode that includes a discussion about…
Natural Immunity Lasts for At Least 18 Months: Study
The protection people experience after recovering from COVID-19, known widely as natural immunity, lasts for at least 18 months, according to a recently published study. Researchers in Italy analyzed the level of antibodies in 36 patients who were documented as contracting COVID-19 in March 2020. About half of the patients went on to get COVID-19…
Combination of Remdesivir and Antibodies Didn’t Work Against COVID-19: Study
A combination of remdesivir and a concentrated solution of antibodies did not work well in people hospitalized with COVID-19, according to a newly published study. The clinical trial tested remdesivir, an antiviral from Gilead Sciences, combined with anti-coronavirus hyperimmune intravenous immunoglobulin (hIVIG), the concentrated solution that, but the combination did not significantly improve favorable outcomes among the…
Experts Divided on US Drug Regulators Revoking Authorization of Key COVID-19 Treatments
January 27, 2022
admin
AMERICABrightCCP VirusFood and Drug AdministrationHealth NewsMind & Bodymonoclonal antibodiesPUBLIC HEALTH INFORMATION
0 Comment
The Food and Drug Administration’s decision to effectively revoke emergency use authorization for two monoclonal antibody treatments has left experts divided, with some calling it the right move and others asserting it shouldn’t have been done. The agency, of the FDA, on Jan. 24 announced it was barring use of treatments from Eli Lilly and…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`